CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $1.61B, above the global median of $1.15B
- PositionGross margin is 1.8%, lower than 95% of its Diagnostics & Research peers (median 47%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
1.61BUSDvs all stocks (USD)
Revenue (TTM)
64.52MUSDvs all stocks (USD)
Profit Margin
-148.11%vs Diagnostics & Research peers
Beta
2.24xvs all stocks
52-Week Change
148.23%vs all stocks
Market Capitalization
1.61BUSDvs all stocks (USD)
Enterprise Value
1.46BUSDvs all stocks (USD)
Forward P/E
-17.17xvs Diagnostics & Research peers
Price to Sales (TTM)
25.29xvs Diagnostics & Research peers
Price to Book (MRQ)
6.40xvs Diagnostics & Research peers
Enterprise to Revenue
22.62xvs Diagnostics & Research peers
Enterprise to EBITDA
-15.74xvs Diagnostics & Research peers
Gross Margin
1.82%vs Diagnostics & Research peers
Profit Margin
-148.11%vs Diagnostics & Research peers
Operating Margin
-207.87%vs Diagnostics & Research peers
Return on Assets (TTM)
-21.41%vs Diagnostics & Research peers
Return on Equity (TTM)
-41.35%vs Diagnostics & Research peers
Revenue (TTM)
64.52MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.6910USDUpdated Jul 19, 2026Quarterly Revenue Growth
-24.90%vs Diagnostics & Research peers
Gross Profit (TTM)
8.85MUSDvs all stocks (USD)
EBITDA (TTM)
-92.69MUSDvs all stocks (USD)
Net Income (TTM)
-95.55MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-79.46MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-42.35MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
69.65MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
53.87MUSDFY2025 · Dec 31, 2025Gross Profit
15.78MUSDFY2025 · Dec 31, 2025Operating Income
-88.06MUSDvs all stocks (USD)
Pre-tax Income
-81.25MUSDFY2025 · Dec 31, 2025Income Tax Expense
21.00KUSDFY2025 · Dec 31, 2025Net Income
-81.27MUSDFY2025 · Dec 31, 2025EBIT
-81.04MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-71.00MUSDFY2025 · Dec 31, 2025Research & Development
50.26MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
53.57MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
7.16MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
205.00KUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-81.27MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-71.04MUSDFY2025 · Dec 31, 2025Free Cash Flow
-75.54MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
126.03MUSDFY2025 · Dec 31, 2025Income Tax Paid
23.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-81.27MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
10.05MUSDFY2025 · Dec 31, 2025Stock-based Compensation
9.43MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.03MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-8.06MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
4.55MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.76MUSDFY2025 · Dec 31, 2025Capital Expenditures
-4.50MUSDFY2025 · Dec 31, 2025Purchase of Investments
-210.17MUSDFY2025 · Dec 31, 2025Sale of Investments
192.11MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-22.57MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
2.59MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-189.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
127.19MUSDFY2025 · Dec 31, 2025Shares Outstanding
104.69MSharesUpdated Jul 19, 2026Float Shares
64.49MSharesUpdated Jul 19, 2026Shares Short
11.31MSharesUpdated Jul 19, 2026Short Ratio
3.11daysvs all stocks
Short % of Shares Outstanding
17.05%vs all stocks
% Held by Insiders
26.67%vs all stocks
% Held by Institutions
68.21%vs all stocks
Total Cash (MRQ)
233.22MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.23USDUpdated Jul 19, 2026Total Debt (MRQ)
38.78MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1522xvs Diagnostics & Research peers
Current Ratio (MRQ)
6.61xvs Diagnostics & Research peers
Book Value per Share (MRQ)
2.43USDUpdated Jul 19, 2026Total Assets
334.16MUSDvs all stocks (USD)
Total Current Assets
267.95MUSDFY2025 · Dec 31, 2025Total Liabilities
72.98MUSDFY2025 · Dec 31, 2025Total Non-current Assets
66.21MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
33.35MUSDFY2025 · Dec 31, 2025Total Current Liabilities
39.63MUSDFY2025 · Dec 31, 2025Cash
4.92MUSDFY2025 · Dec 31, 2025Cash Equivalents
119.33MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
124.25MUSDFY2025 · Dec 31, 2025Other Short-term Investments
115.71MUSDFY2025 · Dec 31, 2025Accounts Receivable
16.20MUSDFY2025 · Dec 31, 2025Inventory
5.26MUSDFY2025 · Dec 31, 2025Accounts Payable
12.99MUSDFY2025 · Dec 31, 2025Short-term Debt
8.08MUSDFY2025 · Dec 31, 2025Deferred Revenue
1.56MUSDFY2025 · Dec 31, 2025Other Current Liabilities
5.46MUSDFY2025 · Dec 31, 2025Long-term Debt
31.87MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.48MUSDFY2025 · Dec 31, 2025Common Stock (Book)
10.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-631.26MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
261.19MUSDvs all stocks (USD)
52-Week Low
3.84USDUpdated Jul 19, 202652-Week High
16.39USDUpdated Jul 19, 202652-Week Change
148.23%vs all stocks
Beta
2.24xvs all stocks
50-Day MA
10.26USDUpdated Jul 19, 2026200-Day MA
8.71USDUpdated Jul 19, 2026Avg 10-Day Volume
4.70MSharesUpdated Jul 19, 2026Avg 30-Day Volume
4.06MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.02USDUpdated Jul 19, 2026Other Income / Expense
-142.00KUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 1.8%, lower than 95% of its Diagnostics & Research peers (median 47%)Significant
Gross margin: 0.02Industry median: 0.47Industry P5: 0.15Peers compared: 28.00
Operating margin is -207.9%, lower than 95% of its Diagnostics & Research peers (median 9.9%)Significant
Operating margin: -2.08Industry median: 0.10Industry P5: -0.95Peers compared: 28.00
Profit margin is -148.1%, lower than 95% of its Diagnostics & Research peers (median 4.5%)Significant
Profit margin: -1.48Industry median: 0.05Industry P5: -0.83Peers compared: 28.00
Return on equity is -41.4%, lower than 95% of its Diagnostics & Research peers (median 2.9%)Significant
Return on equity: -0.41Industry median: 0.03Industry P5: -0.23Peers compared: 28.00
Return on assets is -21.4%, lower than 95% of its Diagnostics & Research peers (median 1.9%)Significant
Return on assets: -0.21Industry median: 0.02Industry P5: -0.13Peers compared: 28.00
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 25.29Revenue Growth YoY: -0.25
Financial Health
Altman Z-Score 10.83: safe zoneNotable
Altman Z-Score: 10.83
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $1.61B, above the global median of $1.15BNotable
Market cap (USD): 1,611,657,698Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Paradeep Phosphates Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hubei Wanrun New Energy Technology Company Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Scantech Hangzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingInterface
Adient plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Dayuan Pumps Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Micronics Japan Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Tayho Advanced Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Dr Agarwal's Health Care Ltd
Tier 1ProductionThroughput-Bound ConversionRule
Tianrun Industry Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen Jame Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
MongoDB Inc.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Denali Therapeutics Inc.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Erasca, Inc.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity